T

Tyche Industries Ltd
BSE:532384

Watchlist Manager
Tyche Industries Ltd
BSE:532384
Watchlist
Price: 120 INR -0.87% Market Closed
Market Cap: 1.2B INR

Tyche Industries Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tyche Industries Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
T
Tyche Industries Ltd
BSE:532384
Free Cash Flow
₹78.2m
CAGR 3-Years
31%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Free Cash Flow
₹18.5B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Free Cash Flow
₹27B
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Free Cash Flow
₹89B
CAGR 3-Years
53%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Free Cash Flow
₹29.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Free Cash Flow
₹13.6B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Tyche Industries Ltd
Glance View

Market Cap
1.2B INR
Industry
Pharmaceuticals

Tyche Industries Ltd. engages in the manufacture and processing of active pharmaceutical ingredients and intermediates. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2000-09-25. The firm primarily manufactures bulk drug intermediates. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal. Its intermediaries include 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, 3-Fluoro-4-methoxy acetophenone, 3-Hydroxymethyl quinuclidine HCl, (RS)-3-Quinuclidinol, 3-Quinuclidinone Hydrochloride and 1-Benzylpiperidine-4-Carboxaldehyde (BPCA). Its nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.

TYCHE Intrinsic Value
120.6 INR
Fairly Valued
Intrinsic Value
Price
T

See Also

What is Tyche Industries Ltd's Free Cash Flow?
Free Cash Flow
78.2m INR

Based on the financial report for Jun 30, 2025, Tyche Industries Ltd's Free Cash Flow amounts to 78.2m INR.

What is Tyche Industries Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-12%

Over the last year, the Free Cash Flow growth was 74%. The average annual Free Cash Flow growth rates for Tyche Industries Ltd have been 31% over the past three years , -12% over the past five years .

Back to Top